We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCP Inc (HCP) Q2 FFO Beats, Life Science Occupancy Peaks
Read MoreHide Full Article
HCP Inc. (HCP - Free Report) – a healthcare real estate investment trust (“REIT”) – reported second-quarter 2016 adjusted funds from operations (“FFO”) per share of 74 cents, beating the Zacks Consensus Estimate of 70 cents.
Results were driven by better-than-expected growth in revenues. However, adjusted FFO per share was down 5 cents from a year ago.
The company posted revenues of $662.2 million, which beat the Zacks Consensus Estimate of $635.2 million. It also compared favorably with the year-ago figure of $607.5 million.
HCP attained year-over-year three-month cash same property portfolio net operating income (NOI) growth of 4.4%, excluding the assets being transferred to Quality Care Properties, Inc. ("QCP") (previously HCP SpinCo, Inc).
The company executed 1.3 million square feet of leasing in its life science and medical office portfolios, comprising 858,000 square feet of renewals and 435,000 square feet of new leases. While occupancy for the life science portfolio reached 98.7%, representing a new all-time high, the same was 91.6% for medical office portfolio.
HCP announced $111 million of investment activities for the second quarter and through Aug 8, 2016, bringing year-to-date total investments to $475 million. Further, the company completed $282 million of dispositions during the second quarter.
HCP exited second-quarter 2016 with cash and cash equivalents of $116.5 million, down from $346.5 million at 2015 end. It ended the quarter with $0.9 billion drawn on its revolving line of credit facility and $1.1 billion of remaining capacity.
Spin Transaction Update
Notably, QCP filed an amended Registration Statement on Form 10 with the Securities and Exchange Commission in Aug 2016. This is in sync with the company’s prior-disclosed plan to spin off HCR ManorCare portfolio, and other skilled nursing facilities, into an independent publicly traded REIT. This spin transaction is expected to close in fourth-quarter 2016 subject to specific requirements.
2016 Outlook
HCP expects full-year 2016 adjusted FFO guidance for 2016 in a range of $2.83–$2.89. The company anticipates 2016 same property portfolio cash NOI growth, excluding QCP, in the 2.3–3.3% range.
Conclusion
We believe that HCP stands to benefit from its diversified portfolio, increases in healthcare spending and an aging population in the long run. Strategic investments, tie-ups and opportunistic acquisitions are expected to drive decent cash flow. Yet, cut-throat competition and any rise in interest rate continue to pose challenges before the company.
HCP currently has a Zacks Rank #2 (Buy).
Investors interested in the REIT industry can consider other stocks like Apple Hospitality REIT, Inc. (APLE - Free Report) , LTC Properties Inc. (LTC - Free Report) and Omega Healthcare Investors Inc. (OHI - Free Report) . Each of these stocks carries the same Zacks Rank as HCP.
Note: FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income. All EPS numbers presented in this write up represent FFO per share.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HCP Inc (HCP) Q2 FFO Beats, Life Science Occupancy Peaks
HCP Inc. (HCP - Free Report) – a healthcare real estate investment trust (“REIT”) – reported second-quarter 2016 adjusted funds from operations (“FFO”) per share of 74 cents, beating the Zacks Consensus Estimate of 70 cents.
Results were driven by better-than-expected growth in revenues. However, adjusted FFO per share was down 5 cents from a year ago.
The company posted revenues of $662.2 million, which beat the Zacks Consensus Estimate of $635.2 million. It also compared favorably with the year-ago figure of $607.5 million.
Behind the Headlines
HCP attained year-over-year three-month cash same property portfolio net operating income (NOI) growth of 4.4%, excluding the assets being transferred to Quality Care Properties, Inc. ("QCP") (previously HCP SpinCo, Inc).
The company executed 1.3 million square feet of leasing in its life science and medical office portfolios, comprising 858,000 square feet of renewals and 435,000 square feet of new leases. While occupancy for the life science portfolio reached 98.7%, representing a new all-time high, the same was 91.6% for medical office portfolio.
HCP announced $111 million of investment activities for the second quarter and through Aug 8, 2016, bringing year-to-date total investments to $475 million. Further, the company completed $282 million of dispositions during the second quarter.
HCP exited second-quarter 2016 with cash and cash equivalents of $116.5 million, down from $346.5 million at 2015 end. It ended the quarter with $0.9 billion drawn on its revolving line of credit facility and $1.1 billion of remaining capacity.
Spin Transaction Update
Notably, QCP filed an amended Registration Statement on Form 10 with the Securities and Exchange Commission in Aug 2016. This is in sync with the company’s prior-disclosed plan to spin off HCR ManorCare portfolio, and other skilled nursing facilities, into an independent publicly traded REIT. This spin transaction is expected to close in fourth-quarter 2016 subject to specific requirements.
2016 Outlook
HCP expects full-year 2016 adjusted FFO guidance for 2016 in a range of $2.83–$2.89. The company anticipates 2016 same property portfolio cash NOI growth, excluding QCP, in the 2.3–3.3% range.
Conclusion
We believe that HCP stands to benefit from its diversified portfolio, increases in healthcare spending and an aging population in the long run. Strategic investments, tie-ups and opportunistic acquisitions are expected to drive decent cash flow. Yet, cut-throat competition and any rise in interest rate continue to pose challenges before the company.
HCP currently has a Zacks Rank #2 (Buy).
Investors interested in the REIT industry can consider other stocks like Apple Hospitality REIT, Inc. (APLE - Free Report) , LTC Properties Inc. (LTC - Free Report) and Omega Healthcare Investors Inc. (OHI - Free Report) . Each of these stocks carries the same Zacks Rank as HCP.
HCP INC Price, Consensus and EPS Surprise
HCP INC Price, Consensus and EPS Surprise | HCP INC Quote
Note: FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income. All EPS numbers presented in this write up represent FFO per share.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>